Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Shares Issued (2016 - 2024)

Historic Shares Issued for Rocket Pharmaceuticals (RCKT) over the last 8 years, with Q4 2024 value amounting to $321000.0.

  • Rocket Pharmaceuticals' Shares Issued fell 1769.23% to $321000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $321000.0, marking a year-over-year decrease of 9021.34%. This contributed to the annual value of $3.2 million for FY2024, which is 4392.65% up from last year.
  • Latest data reveals that Rocket Pharmaceuticals reported Shares Issued of $321000.0 as of Q4 2024, which was down 1769.23% from $176000.0 recorded in Q3 2024.
  • Rocket Pharmaceuticals' Shares Issued's 5-year high stood at $279.9 million during Q4 2020, with a 5-year trough of -$45.9 million in Q4 2022.
  • Moreover, its 5-year median value for Shares Issued was $538000.0 (2020), whereas its average is $15.7 million.
  • Per our database at Business Quant, Rocket Pharmaceuticals' Shares Issued crashed by 20551.01% in 2022 and then soared by 2256052.63% in 2023.
  • Over the past 5 years, Rocket Pharmaceuticals' Shares Issued (Quarter) stood at $279.9 million in 2020, then tumbled by 105.37% to -$15.0 million in 2021, then tumbled by 205.51% to -$45.9 million in 2022, then skyrocketed by 100.85% to $390000.0 in 2023, then dropped by 17.69% to $321000.0 in 2024.
  • Its last three reported values are $321000.0 in Q4 2024, $176000.0 for Q3 2024, and $1.5 million during Q2 2024.